M 511 (Capecitabine 150 mg)
Pill imprint M 511 has been identified as Capecitabine 150 mg.
Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; pancreatic cancer; stomach cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about capecitabine
- Other brands: Xeloda
Related treatment guides
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.